<SEC-DOCUMENT>0001437749-13-010867.txt : 20130814
<SEC-HEADER>0001437749-13-010867.hdr.sgml : 20130814
<ACCEPTANCE-DATETIME>20130814175630
ACCESSION NUMBER:		0001437749-13-010867
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20130814
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20130814
DATE AS OF CHANGE:		20130814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		131039359

	BUSINESS ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719
		BUSINESS PHONE:		6516870414

	MAIL ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bkyi20130814_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD><TITLE>bkyi20130814_8k.htm</TITLE>
<!-- Created by RDG HTML Converter -->
</HEAD>
<BODY style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 10px; MARGIN-RIGHT: 10px">
<P id=PARA1 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT><FONT style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA3 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman, Times, serif"><B>UNITED STATES</B></FONT></P>
<P id=PARA4 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman, Times, serif"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT></P>
<P id=PARA5 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA6 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman, Times, serif">Washington, D.C. 20549</FONT></P>
<P id=PARA7 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA8 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FORM 8-K</B></FONT></P>
<P id=PARA9 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA10 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman, Times, serif"><B>CURRENT REPORT</B></FONT></P>
<P id=PARA11 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA12 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934</FONT></P>
<P id=PARA13 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA14 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Date of Report (Date of earliest event reported): August 14, 2013</FONT></P>
<P id=PARA15 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA16 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL39  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="VERTICAL-ALIGN: top; WIDTH: 101.1%" colSpan=3>
<P id=PARA17 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA18 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA19 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman, Times, serif"><B>BIO-key International, Inc.</B></FONT></P>
<P id=PARA20 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Exact name of registrant as specified in its charter)</FONT></P></TD></TR>
<TR>
<TD style="VERTICAL-ALIGN: top; WIDTH: 33.7%">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top; WIDTH: 33.7%">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top; WIDTH: 33.7%">&nbsp;</TD></TR>
<TR>
<TD style="VERTICAL-ALIGN: top; WIDTH: 33.7%">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top; WIDTH: 33.7%">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top; WIDTH: 33.7%">&nbsp;</TD></TR>
<TR>
<TD style="VERTICAL-ALIGN: top; WIDTH: 33.7%">
<P id=PARA21 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Delaware</B></FONT></P>
<P id=PARA22 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(State or other jurisdiction of incorporation)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top; WIDTH: 33.7%">
<P id=PARA23 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>1-13463</B></FONT></P>
<P id=PARA24 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Commission File Number)</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top; WIDTH: 33.7%">
<P id=PARA25 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>41-1741861</B></FONT></P>
<P id=PARA26 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(I.R.S. Employer Identification No.)</FONT></P></TD></TR>
<TR>
<TD style="VERTICAL-ALIGN: top; WIDTH: 33.7%">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top; WIDTH: 33.7%">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top; WIDTH: 33.7%">&nbsp;</TD></TR>
<TR>
<TD style="VERTICAL-ALIGN: top; WIDTH: 101.1%" colSpan=3>
<P id=PARA27 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA28 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>3349 Highway 138, Building D, Suite B</B></FONT></P>
<P id=PARA29 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Wall, NJ&nbsp;07719</B></FONT></P>
<P id=PARA30 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Address of principal executive offices)</FONT></P></TD></TR>
<TR>
<TD style="VERTICAL-ALIGN: top; WIDTH: 101.1%" colSpan=3>
<P id=PARA31 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA32 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>(732)&nbsp;359-1100</B></FONT></P>
<P id=PARA33 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Registrant&#8217;s telephone number, including area code)</FONT></P></TD></TR>
<TR>
<TD style="VERTICAL-ALIGN: top; WIDTH: 101.1%" colSpan=3>&nbsp;</TD></TR>
<TR>
<TD style="VERTICAL-ALIGN: top; WIDTH: 101.1%" colSpan=3>
<P id=PARA34 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<I>see</I> General Instruction A.2 below):</FONT></P>
<P id=PARA35 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;&nbsp;&nbsp; </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>
<P id=PARA36 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;&nbsp; &nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></P>
<P id=PARA37 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;&nbsp; &nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></P>
<P id=PARA38 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp; Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))</FONT></P></TD></TR></TABLE>
<P id=PARA40.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px">&nbsp;</P>
<DIV id=PGBK40  style="MARGIN-LEFT: 0pt; WIDTH: 100%; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR40  style="TEXT-ALIGN: center; WIDTH: 100%">&nbsp;</DIV>
<DIV id=PGNUM40  style="FONT-SIZE: 10pt; TEXT-ALIGN: center; WIDTH: 100%">&nbsp;</DIV>
<HR style="HEIGHT: 2px; PAGE-BREAK-AFTER: always; COLOR: #000000; WIDTH: 100%" noShade>

<DIV id=PGHDR40  style="TEXT-ALIGN: left; WIDTH: 100%">&nbsp;</DIV></DIV>
<P id=PARA40.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px">&nbsp;</P>
<P id=PARA41 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Item 2.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.</B></FONT></P>
<P id=PARA42 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P>
<P id=PARA43 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On August 14, 2013, BIO-key International, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for its second quarter of 2013. A copy of the press release issued by the Company on August 14, 2013 is attached as Exhibit&nbsp;99. </FONT></P>
<P id=PARA44 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P>
<P id=PARA45 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.</FONT></P>
<P id=PARA50 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P>
<P style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P>
<P id=PARA51 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Item 9.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements, Pro Forma Financial Information and Exhibit.</B></FONT></P>
<P id=PARA52 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P>
<P id=PARA53 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25">
<TABLE  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 5%">
<P id=PARA89 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">(d)</P></TD>
<TD style="WIDTH: 95%">
<P id=PARA90 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Exhibits</P></TD></TR>
<TR>
<TD style="WIDTH: 5%">&nbsp;</TD>
<TD style="WIDTH: 95%">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 5%">
<P id=PARA93 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">99.1</P></TD>
<TD style="WIDTH: 95%">
<P id=PARA94 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">Press Release, dated August 14, 2013, issued by the Company.</P></TD></TR></TABLE>&nbsp;&nbsp;&nbsp;</P>
<DIV id=PGBK95  style="MARGIN-LEFT: 0pt; WIDTH: 100%; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR95  style="TEXT-ALIGN: center; WIDTH: 100%">&nbsp;</DIV>
<DIV id=PGNUM95  style="FONT-SIZE: 10pt; TEXT-ALIGN: center; WIDTH: 100%">2&nbsp;</DIV>
<HR style="HEIGHT: 2px; PAGE-BREAK-AFTER: always; COLOR: #000000; WIDTH: 100%" noShade>

<DIV id=PGHDR95  style="TEXT-ALIGN: left; WIDTH: 100%">&nbsp;</DIV></DIV>
<P id=PARA95.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px">&nbsp;&nbsp;</P>
<P id=PARA59 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>SIGNATURES</B></FONT></P>
<P id=PARA60 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;</P>
<P id=PARA61 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</FONT></P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&nbsp;</P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&nbsp;</P>
<TABLE  style="WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD vAlign=top width="50%"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></TD>
<TD vAlign=top width="38%" colSpan=2><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><FONT size=+0>
<P id=PARA65 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT size=+0><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">BIO-KEY INTERNATIONAL, INC.</FONT></FONT></P></FONT></FONT></TD>
<TD vAlign=top width="12%">&nbsp;</TD></TR>
<TR>
<TD vAlign=top width="50%"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<P id=PARA66 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT size=+0><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Date: August 14, 2013</FONT></FONT></P></FONT></TD>
<TD vAlign=top width="3%">&nbsp;</TD>
<TD vAlign=top width="35%">&nbsp;</TD>
<TD vAlign=top width="12%">&nbsp;</TD></TR>
<TR>
<TD style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #ffffff solid; TEXT-ALIGN: left" width="50%" align=left>&nbsp;</TD>
<TD style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #ffffff solid; TEXT-ALIGN: left" width="3%"><FONT size=+0><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">By: </FONT></FONT></TD>
<TD style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid" width="35%" noWrap align=left><FONT size=+0><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">/s/ Cecilia C. Welch</FONT></FONT></TD>
<TD style="BORDER-BOTTOM: #ffffff solid" vAlign=top width="12%">&nbsp;</TD></TR>
<TR>
<TD vAlign=top width="50%">&nbsp;</TD>
<TD vAlign=top width="3%">&nbsp;</TD>
<TD vAlign=top width="35%"><FONT size=+0><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cecilia C. Welch</FONT></FONT></TD>
<TD vAlign=top width="12%">&nbsp;</TD></TR>
<TR>
<TD vAlign=top width="50%">&nbsp;</TD>
<TD vAlign=top width="3%">&nbsp;</TD>
<TD vAlign=top width="35%"><FONT size=+0><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chief Financial Officer</FONT></FONT></TD>
<TD vAlign=top width="12%"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></TD></TR></TABLE>
<P id=PARA62 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;<FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT>&nbsp;</P>
<DIV id=PGBK96  style="MARGIN-LEFT: 0pt; WIDTH: 100%; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR96  style="TEXT-ALIGN: center; WIDTH: 100%">&nbsp;</DIV>
<DIV id=PGNUM96  style="FONT-SIZE: 10pt; TEXT-ALIGN: center; WIDTH: 100%">&nbsp;</DIV>
<HR style="HEIGHT: 2px; PAGE-BREAK-AFTER: always; COLOR: #000000; WIDTH: 100%" noShade>

<DIV id=PGHDR96  style="TEXT-ALIGN: left; WIDTH: 100%">&nbsp;</DIV></DIV>
<P id=PARA96.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px">&nbsp;</P>
<P id=PARA76 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000"><B>EXHIBIT INDEX</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA78 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 58.7%; LINE-HEIGHT: 1.25; TEXT-INDENT: -274.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB81  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="VERTICAL-ALIGN: top; WIDTH: 15%"><STRONG><U>Exhibit No.</U>&nbsp;&nbsp;</STRONG></TD>
<TD style="VERTICAL-ALIGN: top; WIDTH: 85%"><STRONG><U>Description</U></STRONG></TD></TR>
<TR>
<TD style="VERTICAL-ALIGN: top; WIDTH: 15%">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top; WIDTH: 85%">&nbsp;</TD></TR>
<TR>
<TD style="VERTICAL-ALIGN: top; WIDTH: 15%">
<P id=PARA82 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">99.1</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top; WIDTH: 85%">
<P id=PARA83 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Press Release, dated </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">August 14, 2013, issued by </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the Company.</FONT></P></TD></TR></TABLE></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML><HEAD><TITLE>ex99-1.htm</TITLE>
<!-- Created by RDG HTML Converter -->
</HEAD>
<BODY style="FONT-FAMILY: Times New Roman; MARGIN-LEFT: 10px; FONT-SIZE: 10pt; MARGIN-RIGHT: 10px">
<P style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA1><B><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Exhibit 99.1&nbsp;</FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 24pt"></FONT></B></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA2><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 24pt"><B><I></I></B></FONT>&nbsp;</P>
<P style="LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt">
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"  cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 60%" rowSpan=2>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA103><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 20pt"></FONT></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt"><IMG style="WIDTH: 144pt; HEIGHT: 108pt" src="ex99-1img001.jpg"></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt"></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt"></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt"></P></TD>
<TD style="WIDTH: 10%" colSpan=2>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA3><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 20pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 20pt"><FONT style="BACKGROUND-COLOR: #ffffff; COLOR: #000000; FONT-SIZE: 20pt"><FONT style="COLOR: #000000; FONT-SIZE: 20pt"><I><B><FONT style="COLOR: #000000; FONT-SIZE: 10pt"></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA109><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 24pt"><B><I>NEWS RELEASE</I></B></FONT></P></FONT></B></I></FONT></FONT></FONT></FONT></TD></TR>
<TR>
<TD style="WIDTH: 10%; VERTICAL-ALIGN: top">
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA104>&nbsp;</P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt">Contacts:</P></TD>
<TD style="WIDTH: 30%">
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA105><U>BIO-key International, Inc.</U></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt"><U></U>Jay M. Meier, VP Corp Dev.&nbsp;</P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">651-789-6116</FONT></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt">Jay.meier@bio-key.com</P></TD></TR></TABLE>&nbsp;</P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA15><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 11pt"><B><I>BIO-key&#174; International, Inc. </I></B></FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA16><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 11pt"><B><I>Reports Second Quarter 2013 Financial Results</I></B></FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA17><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><I>&nbsp;</I></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA18><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><B>&nbsp;</B></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA19><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><B>Wall, NJ, August 14, 2013</B> &#8211; BIO-key International, Inc. (OTCBB: BKYI), a leader in fingerprint biometric identification technologies, Cloud-based mobile credentialing and identity verification solutions, today reported financial results for the second quarter ended June 30, 2013.&nbsp; </FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA20><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><B>&nbsp;</B></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA21><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><U>Three Month Comparisons</U></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA22><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA23><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Total revenue for the three months ended June 30, 2013 was $422,257,&nbsp;compared to Q2&#8217;12 revenue of $532,713, a decrease of roughly 21%. The reduction in sales, year over year, resulted primarily from lower license revenue that was partially offset by higher service revenue. Q2&#8217;13 non-recurring service revenue increased 177%, resulting largely from special development projects related to our joint-development agreement with InterDigital Corporation. Q2&#8217;13 sales remained more diversified, with three customers accounting for 51% of sales and five customers accounting for 78% of receivables as compared to Q2&#8217;12, when two customers represented 81% of sales and 88% of receivables, respectively. Michael DePasquale, BIO-key CEO, noted &#8220;Although I am disappointed with orders slipping from our second quarter, it&#8217;s the nature of our emerging business. We are, however, tracking to plan with InterDigital, our sales and collections remain more diverse, and we continue to manage expenses well.&#8221; </FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA24><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA25><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Q2&#8217;13 gross margin increased to 78% from 73% in Q2&#8217;12. Operating expenses for Q2&#8217;13 decreased 13%, year over year, to $867,475 from $998,220 in Q2&#8217;12.&nbsp; Net loss for Q2&#8217;13 was ($554,831), or ($0.01) per diluted share, as compared to net loss of ($613,419), or ($0.01) per diluted share, in Q2&#8217;12. Mr. DePasquale continued, &#8220;We achieved some of our goals during the quarter, including gaining new certifications and OEM relationships, while holding down expenses. While we see indications of demand pull, we need to execute more tactically to grow the top-line near-term.&#8221;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA26><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA27><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><U>Six Month Comparisons</U></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA28><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA29><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Total revenue for the six months ended June 30, 2013 was $1,226,900,&nbsp;compared to $1,943,140 for the six months ended June 30, 2012, a decrease of 37%. The reduction in sales resulted primarily from a 63% decrease in license revenue. </FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA30><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT>&nbsp;</P>
<DIV style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" id=PGBK106 >
<DIV style="TEXT-ALIGN: center; WIDTH: 100%" id=PGFTR106 >&nbsp;</DIV>
<DIV style="TEXT-ALIGN: center; WIDTH: 100%; FONT-SIZE: 10pt" id=PGNUM106 >&nbsp;</DIV>
<HR style="PAGE-BREAK-AFTER: always; WIDTH: 100%; HEIGHT: 2px; COLOR: #000000" noShade>

<DIV style="TEXT-ALIGN: left; WIDTH: 100%" id=PGHDR106 >&nbsp;</DIV></DIV>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" id=PARA106.2>&nbsp;</P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA31><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">For both the six months ended June 30, 2013 and 2012, gross margin was 83%. Operating expenses for the six months ended June 30, 2013 increased less than 1% to $1,862,360 from $1,857,591 in 2012.&nbsp; Net loss for the first half of 2013 was ($870,409), or ($0.01) per diluted share, as compared to a net loss of ($249,921), or less than ($0.01) per diluted share, for the first half of 2012. </FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA32><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA33><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA34><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><U>Liquidity and Capital Resources</U></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA35><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA36><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">The Company reported cash and cash equivalents of $99,573 at June 30, 2013 compared to $83,989 at December 31, 2012. </FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA37><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA38><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><U>Financing transactions in 2013 included the following:</U></FONT></P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA39><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA40><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">On February 26, 2013, we issued a promissory note in the principal amount of $497,307 (the &#8220;InterDigital Note&#8221;) to DRNC Holdings, Inc. (&#8220;DRNC&#8221;).&nbsp;&nbsp;The InterDigital Note accrues interest at a rate of 7% per annum and matures on December 31, 2015. At June 30, 2013, $497,307 remained payable under the InterDigital Note.</FONT></P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA41><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA42><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">On February 26, 2013, we issued 4,026,935 shares of common stock to DRNC for an aggregate purchase price of $402,693.&nbsp;&nbsp;DRNC has certain anti-dilution rights as defined.</FONT></P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA43><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA44><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">On February 26, 2013, we also issued 5,000,000 shares of common stock to a limited number of investors for an aggregate purchase price of $500,000.</FONT></P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA45><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA46><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">On July 23, 2013, we issued to certain investors, 3,500,006 shares of our common stock at a purchase price $0.30 per share, for an aggregate purchase price of $1,050,000, and 3,500,006 warrants to purchase additional shares of common stock at an exercise price of $0.40 per share. The warrants will expire five years after the date of the grant.</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA47><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA48><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Mr. DePasquale concluded, &#8220;Our recent working capital raise from existing accredited investors provides us with flexibility to continue to invest in sales, marketing and R&amp;D as we position ourselves to compete for business in the oncoming Mobile Credentialing build-out. We are very excited about the opportunities we see emerging.&#8221;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA49><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA50><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA51><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA52><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><U>Highlights for the second quarter included the following: </U></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA53><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt" id=MTAB55  border=0 cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA56><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&#9679;</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA57><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Received IBM Certification for ISAM for Web. BIO-key is the premier finger biometric authentication solution for ISAM, which connects IBM customers to enterprise applications, eliminating the use of passwords or other cumbersome, less secure authentication solutions</FONT></P></TD></TR></TABLE>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt 0pt 0pt 18pt" id=PARA58><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT>&nbsp;</P>
<DIV style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" id=PGBK107 >
<DIV style="TEXT-ALIGN: center; WIDTH: 100%" id=PGFTR107 >&nbsp;</DIV>
<DIV style="TEXT-ALIGN: center; WIDTH: 100%; FONT-SIZE: 10pt" id=PGNUM107 >&nbsp;</DIV>
<HR style="PAGE-BREAK-AFTER: always; WIDTH: 100%; HEIGHT: 2px; COLOR: #000000" noShade>

<DIV style="TEXT-ALIGN: left; WIDTH: 100%" id=PGHDR107 >&nbsp;</DIV></DIV>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" id=PARA107.2>&nbsp;</P>
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt" id=MTAB60  border=0 cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA61><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&#9679;</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA62><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Received CA Validation for SiteMinder. BIO-key is the premier finger biometric authentication solution for SiteMinder. CA is the leading integrator in the financial industry.</FONT></P></TD></TR></TABLE>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt 0pt 0pt 36pt" id=PARA63><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt" id=MTAB65  border=0 cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA66><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&#9679;</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA67><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Caradigm, a GE Healthcare and Microsoft Company, agreed to become a BIO-key OEM partner; offering BIO-key technology within their SSO and IAM solutions for healthcare organizations. BIO-key is their exclusive biometric authentication partner.</FONT></P></TD></TR></TABLE>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt 0pt 0pt 36pt" id=PARA68><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt" id=MTAB70  border=0 cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA71><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&#9679;</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA72><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Received a Purchase Order from Knox Community Hospital (OH); which became the first BIO-key / Allscripts Pro EHR integration customer. Allscripts PRO EHR is the largest of the Allscripts platforms, serving small to mid-size practices, clinics and hospitals.</FONT></P></TD></TR></TABLE>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA73><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt" id=MTAB75  border=0 cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA76><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&#9679;</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA77><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Received initial PO from IntrinsiQ oncology EHR providers for customers in the U.S. IntrinsiQ will OEM our technology; presenting it to customers and prospects.</FONT></P></TD></TR></TABLE>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt 0pt 0pt 18pt" id=PARA78><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt" id=MTAB80  border=0 cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA81><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&#9679;</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA82><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Launched the Nigerian Communications Commission National SIM Card registration program, utilizing BIO-key technology to enroll and de-dup over 110,000,000 SIM cards and user credentials. </FONT></P></TD></TR></TABLE>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA83><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt" id=MTAB85  border=0 cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA86><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&#9679;</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA87><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Purchase orders from My Life Plan, Union Pacific, Identimetrics, Davlong, MedFlow, Suncoast, NCR, Phillips and Associates and LexisNexis for continued rollouts.</FONT></P></TD></TR></TABLE>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA88><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff; MARGIN: 0pt" id=PARA89><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">In conjunction with this release, BIO-key has scheduled a conference call, which will be broadcast live over the Internet on Thursday, August 15th, 2013 at 10:00 a.m. Eastern Time. Participate live via phone by dialing 1-877-317-6789 and asking for the BIO-key Call at least 10 minutes prior to the start time. International callers should dial 412-317-6789. Or join the call live over the Internet by logging on to the web address http://www.bio-key.com</FONT></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA90>&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff; MARGIN: 0pt" id=PARA91><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">A streaming audio replay of the webcast will be available shortly after the call on www.bio-key.com for a period of thirty days. You can also access the recorded call by dialing 1-877-344-7529 and using access code 10032625. International callers should dial 412-317-0088 and use the same access code. </FONT></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA92>&nbsp;</P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA93><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA94><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><B>About BIO-key</B></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA95><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key&#8217;s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world&#8217;s largest identification deployments to improve security, guarantee identity, and help reduce identity theft. &nbsp;BIO-key&#8217;s technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA96><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT>&nbsp;</P>
<DIV style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" id=PGBK108 >
<DIV style="TEXT-ALIGN: center; WIDTH: 100%" id=PGFTR108 >&nbsp;</DIV>
<DIV style="TEXT-ALIGN: center; WIDTH: 100%; FONT-SIZE: 10pt" id=PGNUM108 >&nbsp;</DIV>
<HR style="PAGE-BREAK-AFTER: always; WIDTH: 100%; HEIGHT: 2px; COLOR: #000000" noShade>

<DIV style="TEXT-ALIGN: left; WIDTH: 100%" id=PGHDR108 >&nbsp;</DIV></DIV>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" id=PARA108.2>&nbsp;</P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA97><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><B>BIO-key Safe Harbor Statement</B></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA98><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Certain statements contained in this press release may be construed as &#8220;forward-looking statements&#8221; as defined in the Private Securities Litigation Reform Act of 1995 (the &#8220;Act&#8221;).&nbsp; The words &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intends,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;believes&#8221; and similar expressions are intended to identify forward-looking statements.&nbsp; Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the &#8220;safe-harbor&#8221; provisions of the Act.&nbsp; These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected or implied by such statements.&nbsp; These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, market acceptance of biometric solutions, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel.&nbsp; For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2012 and its other filings with the Securities and Exchange Commission.&nbsp; Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.&nbsp; The Company undertakes no obligation to disclose any revision to these forward-looking statements. </FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA99><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA100><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&#169;</FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"> Copyright 2013 by BIO-key International, Inc.</FONT></P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1img001.jpg
<TEXT>
begin 644 ex99-1img001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``4$!`0$`P4$!`0&!04&"`T("`<'
M"!`+#`D-$Q`4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!#`04&!@@'"`\("`\@%1(5("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("#_P``1"`"0`,`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#[+S29HHH`
M,T9HJK?W]EIEA+?ZC=PVEK"NZ2:9PB(/4DT-C2;=D6LTV25(T9W9411DLQP`
M/<U\^>,_VDM.LWDLO!-A_:4PROV^Z!2$>ZIPS_4[1]:\"\2>.O%WBZ5F\0:]
M<W<9.1;JWEPK]$7`_/->;6S"E#2.K/I,'P[BL0N:I[B\]_N_SL?8VN_&'X=^
M'G:*\\2V]Q.O6&SS<-]/DR!^)KSW4_VH/#T+%=(\,ZC>@='GD2`'_P!"/Z5\
ML(F76.-"68X5%&23Z`#K7>:!\'_B+XB19;/PY+:V[#(FOV%NI'J`WS'\JX?K
MV(J.U-?A<^@60Y=A8\V)G?U=OZ^\]#NOVH?$+L?L7A33XE[>=</(?T"U3_X:
M=\9_]`#1ORE_^*J_I?[+^KR@-K7BNTMN.4M+=I3^;%?Y5U-K^S#X5C&;SQ%J
M]P?]@1Q_^RFK4,=+6]ON.>5;(*>BC?Y29QT'[4'BE6'VKPQI<J]_+ED0_KFN
MDT[]J/2W*KJWA*\@'=[:X24?DP6MW_AFGX?[,?;=:W8Z_:4_^(K+N_V7_#3C
M_0O$VJVY_P"FB1R#^0K10QT=FF<TJV0U-'!K[_\`,[31/CG\-M;=8AKHTZ9N
M!'J$9AY_WC\OZUZ);7EM>6Z7-I<17$+\K)$X=6^A'!KY<U;]F'Q!`&;1O$MA
M>@=$N86A8_B-PKC'\)_&#X8W#7UE::G81)RT^GOY\##_`&E7(Q_O+6BQ5>G_
M`!H:=T<\LJR_$?[GB->TOZ3_``9]N9HS7S5X*_:5+/'8^.K``?=_M&R4X'O)
M%_5?RKZ'TK5M-UO3(M2TF^AOK.892:%PRM_]?VZUW4<13K+W&>%C,OQ&#E:M
M&WGT?S+V:,T45N<`9HS110`9HS110`9I0<TE`H`*0D#K2FO-OBM\4++X>Z(L
M=NJ76NW:G[+;$\*.AE?'\(].YX]2(G.-.+E+9&U"A4Q%14J2NV7OB'\3O#_P
M]TT/?.;O4IE)MM/B8>9)_M,?X5S_`!'\,FOC_P`:_$#Q-X\U'[1KEX1;(V8+
M&$E8(?HO\1_VCD_2L'5-4U'6]5N-6U:\DO+ZY;?+-(>6/]`.P'`J70M"U;Q+
MKEOHNB63WE]<'"1KP`.[,>BJ.Y-?-XC%5,1+ECMV/T[+LHP^70]K4LYK=O9>
MG;UW,\!F9552S,0JJ!DD]@!W->U>!/V>_$'B&.+4?%,SZ%I[_,L&T&ZD'T/$
M8^N3[5[/\-/@UH7@:&+4;T1ZIX@(RUVZ_)`>ZQ`]/][J?;I7J0&*[L-ER2YJ
MWW'@YEQ+*3=/!Z+^;_+^ON.3\*_#KP?X,B4:#HD,5P!AKJ4>9,WU=N?P&!76
MT45Z\8J*M%6/C:E2=67/4;;\PHHI,U1F+16'XA\6^'/"EF+OQ#K%MI\;?=$K
M_._^ZH^9OP%>/:W^T]X9LW:/1-"OM2`X$LS+;H?IG+?H*PJ8BE3^.5CNPV7X
MK%:T8-KOT^_8]\R*.W%?-5O^T#\0-5(?1?AM]IC/0HD\N?Q50*U8?CCX]LL/
MKWPDU)8A]YX%F7'X,A'ZUDL92??[F=DLEQD=&E?MS1O^9Z)XP^$O@KQFCR:A
MI26M\PXOK/$4H/OCA_\`@0->%WGA'XE_`S5)-=\-W1UC0=VZX"*2C+_TVB'*
MG'\:]/4=*]=\.?'GP#KMREC>74^@W[$#R-33RQGTW\K^9%>H!HYX@R,KHZY!
M!!#`_P`Q4RI4JWOTW9]T7#%XS`_N,1&\']F6WR?3Y'&?#WXDZ%\0M&-WIS_9
M[V$#[58R,#)"3W']Y3V8?H>*[;->$>//A3J&@:P/B%\*\V.KVI,L^FPCY+A?
MXMB].>Z=#VP>OHWPZ\>:=\0/"L>K6BB"[B/E7EH3\UO*.H^AZ@^GN#6E*I)/
MV=7XOS.7%8:GR?6,*[P>Z>\7V?EV9V5%%%=1Y@4444`%`HH%`&!XP\4Z=X,\
M*7WB'4F_=6R_)&#AII#PJ#W)X_7M7P;XB\0:IXI\17FO:Q-YMY=ON;'W8U_A
M1?15'`KUK]HKQH^L^,X_"EI+FQT;YI@#P]PPYS_NJ0/J6KQ&OF\?B'4G[-;+
M\S],X>RY8>A]8FO>G^"Z??O]Q9T_3[W5M4M=+TVV>YO+J010Q)U=CT'_`-?L
M*^W/AA\-=-^'OAX0A4N-8NE#7MYCEC_<7T0=AWZFO-?V=_`T%AI$WQ!U=$26
MX5HK$RX`BA'#R9/3<01GT'O7I^J?&+X5Z-.;?4?B!H<<J\%$O%D(^H7.*[\!
MAE"/M9;O8\'B'-'6J/"TG[L=_-_Y+\SN@,4M<5H/Q8^&OB>]6RT+QOI%Y=/P
MD`N561_8*V"?PKL+BYM[2VENKNXCM[>%2\DLK!511U))X`]Z]4^1):*Y?_A8
MOP^QG_A.O#W_`(,X?_BJV-*UO1==MFN=$U>RU2!&V-)9W"3*K>A*D@'VH`OD
MXKPWXO?&T>%9Y?#/A5HY];48N+I@&CL\CH!T:3VZ#OGI7M\[QQP/)+*L2*I+
M.Q`"CUR>E?&:>#_A[HOC^2;QS\6?#=WI2SM,\<-YYEQ=$L3MD"YV9/WCDY[8
MSQR8EUK*-);]>Q[&51P:J2J8QZ15TN[_`*Z#O!/PL\7_`!4U!O$6N:C/;Z=*
MV7U*[)DEN/41*>H]^%';-?2?A7X2^!/"<:-8Z%#<W:CF[O0)I2?4$\+_`,!`
MK5\+^,O!'B6V2#PEXCTG4HX4"K!97",8U`X&P'*@#VKIJ5'"0I:[ON/'9OB,
M4^5/EATBM%_P1%554*HP!P`.U+1178>,8FO>$O#/B:V:WU_0[/4488S-$"P^
MC=1^!KSX>%/$OPO8W_@>>ZUSPVIW7/AVYDWRPKW:U<]Q_</7ZUZ/KOB/0/#&
MG'4?$6M66DV@./-NYUB4GT&3R?85>M+NUU"Q@OK&YCN;6X198IHF#)(A&0RD
M<$$'K64J49.ZT?<ZJ6)J4UR/6/9[?\#U6I2T/6]-\1Z);:SI%R+BSN5W(X&"
M.Q5AU#`Y!!Y!%>3^--*E^&?CJ+XHZ#"RZ/=NMOXALXE^78QP+@`=P3D^_P#O
M&NVCL!X6\=_:+-1'I'B.0K<0CA8;T+E95';S%4JW^TJGJ3767]E:ZEIMSI]]
M`L]K<QM%+&PR'5A@C\C4RBZD;/=?F:TZJP]2\=826J[I[KU71]TF2P317-O'
M<02K+%*@='4Y#*1D$>V*EKSOX5R76F:5JG@?49FENO#%T;2*1^LMJPWV[G_@
M!V_\`KT.M(2YHIG-6I^RJ."=UT\UT?S0M%%%68A0**!0!^<FHWUQJ>K7NI7;
MF2XNYWGE8]V9B3^IJQH&BW/B/Q)IN@V8)FOYU@!`^Z"?F;\%R?PKZ5\2?LTZ
M-J.KSWN@Z_-I,4[ES:R0"9(R3DA#D$#T!SBNQ^''P<T#X?3/J*W$FJ:PZ&/[
M7,@41J>JQJ,[<]SDDU\[#+ZKJ>_MW/TJMQ'A(X>]"_-;16V?F]M/(^>OVOO"
M_B+1M`\.W]AK[1^#[=(]+BT="4"2A7;S"!P^57&3R,>YKS7]F_X+:!\7-4UV
M7Q)?WD%CI"0XALV5'E:0OC+$'``0]!DYZU]`_MI#_BS&CGTUJ/\`]$RUY9^R
M=XX\+?#_`$#QQKGB[5X],L7ELH(W96=I'(G.U54$DX!/`KZ)*VB/S9MMW9E_
MM"_L[:7\+-!LO%GA34[RXTR6Y%K/;WC*TD+L"4974#*G:1@C(..3GCTO]FSQ
M;/\`%_X:>)OA7X]FGU2WM((UCG:4B5[=R1L+]249003V..@KA/VD?V@O#GQ)
M\.V7@WP7'=3V2W2W5S>S1&,2,H8(B*?FQ\V22!T%>M?LF_"?6_`_AW5/%/B:
MSDL-0UL1QP6<HVR10+D[G'\)8GH>0%'K0(^,OBEX9T[P;\5_$?A?27F>QTZ[
M:&$SL&?;@$9(`SU]*_0#X7^#O`_P4^#\WB:&>XAM[K3X=2U.ZN)=Y8B+=A5&
M`.68``9)(&37PU\?O^3AO&O_`&$&_P#017TE^TQXBGTO]F#P1H-NY0:S':";
M!^]'%`KD?]]%#^%`'A'COXG_`!!^/WQ`M]!TP7$=C=W'D:=HD$F(P.S2=F;'
M+,>`,XP*]Y\._L3^'$T>,^*O%NHS:DZ9D&G*D<,;>@WJQ;'J<9]!7#?L4^'X
M+[XB^(/$4\0=]+L5AA)'W7F8Y(]]J,/^!&ON^@#\Y_C#\`/$GP6DM_%OA_6Y
M[_15F55OH08;BRD/W=^T]">`XQSP0,C/T)^S-\>+SXA6LO@[Q=.LGB.QA\V"
MZP%-]",`[A_ST7(SCJ#GJ#7MGQ"\/6_BKX:>(_#UR@=+ZPEC7/9]I*-]0P4_
MA7YC?"CQ%<^%/C#X6UNVD*&#48DDP<;HW;9(OXJS"@#]8:***`/S6_:9\(:Y
MX1^+#+K?BJY\1_VI";^WEN<AH(VD=1%@D@`;?X<#'85]S?`\D_`+P1G_`*!,
M'_H-?)W[;'_)6/#W_8&7_P!'RU[#HOQN\+_"'X#?#6/Q#IVJ7CZCI$;1?8H5
M95"J,Y9F49Y'`R:`/H74]/74K18&?RRDL<R.!DJR.&!'Y8_&KIZ<5X;\/_VG
M?!/Q%\:V?A/1]$UV"\NPY22>WC,:[5+'<5<E1@'G'7%=;\3?C-X(^%-G$WB.
M\DFO[A2UOIUHH>>4?WL$@*N>,L1[9Q1;J.[M8U+BV&G?%ZQU!.$UG3);68#O
M)`X>,GWVR2#\*[$5\BG]LGP5J&NZ;<:AX+UFWALIFD2:*XB=AN1D.4.,C#$X
M#=A7H?B/]JGX9>'],TC4;8:GK=MJD32(]C`N(2IP8Y-[+M<'^'TP>A&9BK-E
MSGS*/=*W]?(]XHKY\\*?M9_#_P`6^+]+\,V.AZ_#=:G<+;1/);QLJLQP"VUR
M0,]3C@<]JV?B3^TAX,^&'C!O"^MZ1K5U>)"DS/:P)Y>&&0`7==WO@8[=0:HS
M/:J!7C7A#]HGPAXV\/ZCJND:5J\1L95A,-U"J>865FR'#%<*%);G(R."6`/H
MOACQ3:^);>5HK>2VGAP7B<A@5)8!E8=1E7'8@JP(!%`'08&>E%%%`'S/^VD/
M^+*Z2?36HO\`T3-7E7[*/@/PK\0_#/C?1?%VE)J-DD]E-&I=D:-P)AN5E((.
M"1UYKOOVTO$FAGP%I'A1=3A;6O[1CO6LE.9%A\N5=[#L,D`9ZUSO[#U[;)=^
M-=/>XC6YE6TECB+`,ZKYH8@=P,C/U%`%?X__`+,WAGP=X#N/&_@1KJVCTXJ;
MRQGE,JF-F"[T8_,""1D$G(STQS)^R5\8M?N_%'_"M/$6H2ZA9W$#RZ;+<.7D
M@=!N:+<>2A4$@'H5XZU[#^U#XVT7PY\$M8T.YNHFU;7(Q:VMH&!=@6!=R.H4
M*#SZD#O7R]^R-X<OM7^/%KK,,+FST6VFGN)0/E4NC1HN?4EB<>BGTH`XKX_?
M\G#>-?\`L(-_Z"*]Y_:ILII/@1\+=0528H(DA8^A>V0C_P!%FO!?C\0?VA?&
MI!!_XF#?^@BONCQGX`_X67^S%8^&K<J+\Z5:7-B['`$Z1*5&>P897/HU`'AO
M[#U]$NK>-=-8@2R0VLZCN0K2*?U9?SK[5K\N_@_XZO/@U\9(-2UFSN(8(V?3
M]5M"I$BQD@-\I_B5E5L=]N.]?I7H'BGPYXHTB+5_#VMV>I64J[A+!*"![,.J
MGU!P10!9UN\AT[P[J>H7#!8;6UEF<GLJH2?T%?DKX2M)M3\>Z#96ZEI;K48(
MD`]6E4#^=?:_[3OQRT#2_`^H>`/#.J0ZAK>J)]GNVMG#K9PG[X9AQO8?+MZ@
M$DXXSY+^R3\+KSQ%X_7Q_J5HRZ+H3$VSNORSW1&%"^H0'<3V.V@#VGQQ^UQX
M>\%^/-9\*/X0U"^?2YS;O<+<)&'<?>PI!P`>_>N;_P"&X-`_Z$#4/_`Y/_B:
M^@=9^$GPS\0ZQ<:QK?@C2;[4+DAIKB6`%Y"!C)/<X`YK/_X45\'_`/HG>B_^
M`XH`^/\`]KG6;?Q%XR\%:]:1O';ZEX;@NXTD'S*LDDC`'W`-9-[\0-0^*GA_
MX<?`[0[F'2=+ABMK6ZNKS"B:Y`QG_<7)"C@LQ^E=%^V?!!:?%+PW:6L*000:
M%'''&B[511-*``!T``Q7'?$#X.W'A_X1^"_BCX=CE;3M1T^`ZB`Q+6MR1Q(#
MV1S^3?4"@#[\\#^!/#'PQ\%Q:-H5FD,%K$6GN64>;<,!EI';N3CIT'0<"OSK
MTJ6]^-O[1UE_;US(ZZ]J@\[YO]7;`D[%]`L:X'TK[`_9V^,D/Q2\$S>$_$=T
M/^$HT^W,4S,?FO8"-HF'JPR`WO@]^/B2RTQ?`WQ@;0?%,UWI\-E>2Z??3VQV
MRQ1.&B>1/7Y&+#U'UH`^C_VD?B)\(O\`A`/^%9^$-,T_4=3MY(U@FL(E$.F[
M&&0KC[S$`J0N1R<G(Q3?@#\"_$FJ?"[QG9>-;!]-TOQ':QII]O=)^]29=Q2Y
MV'E,$KCH6&>V,^P?"SX$_"KX>:5!XJMKBW\07.SSX]<O71HHUZAHQG8@Q_%R
M?>NJ\&?&KP)X_P#'&J>$?"]]/>W6FPF=KD1?Z/,H8*QC?/."P&2`#GC(H`^)
M_P!GCQ+-\,?VAXM&\01+;)>RR:+>"0#,$I?"G)Z8D4`GT8U[!^UMJDWBKQGX
M+^$NAQQRZE=3K<2G:"R-(WEQ+GJ!CS&/M@UPG[7_`(";PY\2[/QQI\1BL]?3
M]ZR<>7=1@`GCIN7:WU#&M_\`9IM=8^)OQKUOXO>,)DGDTBV2-9V7:GGM'Y:D
M9X&V)6)]V!H`^H3\,M%@\`Z1X2TPI90Z5"L43^4&64;0L@E3C>'ZMR#GG-;'
MA7PM'X;AFW70N)I56-1''Y<4$2EBD4:9)"@NW4D\]<``>7:]^TIX5TW5)+/2
M=)O=:BB;:;J-UBC<_P"QNY8>^!FNW^'WQ3\-_$-9XM,\ZTU"W4/+9W(`<+G&
MY2"0RYXR.G>N>&)I3ER1EJ>A5RW%TJ?MJE-J/?\`S['>T445T'GGCWQ9_9[\
M&_%B^36+^XNM*UN.,0B]M2")$&<!T;AL9.",'WKP6Y_8H\3V=YYVA?$*R)4_
M(\MM)`X_%2U?;=>7_M!7]_I?[/GBW4-,O;BQO(8(C'/;R&.1#YT8.&7!'!(_
M&@#P'2OV*M4NM0%SXN^(2R(?OBSMVDD;VWR'C\C7T-9_![PWH/PGU/X?>#;B
MZ\.QZA$5?4K=MUTTAQ^\9N"QXQ@8&"0,5Y)X^\9^,/"?QZTG7M+NKN]T+1_"
MUM?ZUI@E9EEMGG:.694Z%TRK9ZX7KC-=/\-;&'XH>#_&L=[XHUF33QXPO);*
M\T[4I(9/(`4QHK@Y$>'SM'%`'F\O[$*S3/--\3)I)'.YG?3,LQ/4DF7DU[M\
M'/A1/\)_#U]I,WBZ^\0I<RJ\8N$\N.V501MC3<V,YYY[#CBO+OA!I-T_[/.M
M_$&Z\4>(KW6I=,U6#_2]5EEBCV-($=48X5P(U^8<]?6J?P8L;_4V\&ZMJ&B_
M$V2::**XDU.ZUHR:=*VS=O,9D),;'H".XH`]/^*?[/W@7XIR'4K^&72]<"A1
MJ=D`'<#H)%/$@`[G![9Q7SW<_L3^+(+IUTKQ]IKVS<%I8)8G(]PNX'\ZL>+/
M$<=KXN^)EUKFH?$,2VNM/9:7=:-J+PV%I(R#RDD+.%3YR#R,8-=M\1KOXM:5
MH/P;M+'5GD\:8N)KN**?]WJ$D-NLIBDV_+)N52OH2V1US0!E^#_V*]#L;Z*Z
M\:>*IM7B1MQL[&'[.C^S.26(^@4^]?5&D:1I>@Z/:Z/HUA#8:?:((X;>!`J(
MH[`?KGN>:\2^%/Q$M?&OQ6\;>(K;59AH?]C:;<K;33$I8OLD\Y2O16#*0V!S
MC->?_#/XMS7?QMLM?U'QG%>Z5XZN;NSBT4W>]M(,;@6A:/=\AD4$=!DMDT`?
M7=)VS7S1K?P]A7]HO1?"">,_&2:7J>D76HS(NO3@B59`%VG/"@$\5J:IXIUC
MPG\5_BM<VMW=7D&@^$K>[M+2>9GC6148[MI.,D@%CU-`'*^*_P!D"\\6>*+[
M7=1^*E]<O<RNZ&\LO.>-2Q(3=Y@X&>P`]A7IWPP^",?@/P3K?A'7_%%SXMTC
M55$7V.ZBV0P1[2&5%+-@MNR<$?=&!GFO-=5T#7O#7[/]I\:;/XD>(+CQ9':6
MVKS/<7QDLKGS2A:W,'W`F'V@#N!4WCCQ[XN\._M`6/BNPENI?#NG>&K34-:T
M@2,RBVEF9))5CZ%XR5;/7"]<9H`S8?V,?[,\0?VIX>^*%_I7EREX'BL\30KV
M`D61<G'&<#/I7IOQ0_9U\*?$VRL[F]OKFQ\1VMNEO_;$:*SW(50`9DX#GOD8
M(Z9QQ6/X"^(L>C?!OXF>/+[5I-5L]/\`$.IR6,DLQD62/*>1&A)X4EE``X&Z
ML7]G+QM>?\)3J?@C7/&T7BJZU"P@UZWN4N_M'D2.H%Q;9R<%&VX7CC)QS0!P
M]O\`L6>)=RV-U\2H%TO=DI%:R'//787"Y_&OI#X6_"#PC\)M%EL_#T,DU[=8
M^UZA<D&:?'0<<*HYPH_')YK)^!&J:GJOACQ7+JFH7-])!XIU&")KB4R%(U<!
M4!/11V'05ZK,[I`[QQ^8ZJ2J9QN..!GM0!\N_MF>+]$L_AYIW@J6*.YUC4;E
M;R/)YM8H\@R?5B2@]1N]*S&L#\)?V2M$\+J?L^N^*6^TW@'#A7`=P?H@CC/U
M-<78_!_XL_$7X_Q^+OBGX<DTO1Q=_:[Z6>>,PQ6\7*P)ACE<`+]"2>]'Q4\;
MGQWX]N=3@<_V9;#[+8J>/W0/+X]6.3],#M7!CJWLZ5ENSZ#(<"\5BE)KW8:O
M]$</TX%>U?LUZ7=77Q-N]4C4BVL;%UE?'!:1@%7Z_*Q_"O%"0H))X%?;'P/\
M'2>$?AO;F\A\O4M4;[;<`CE-P&Q#]%Q^)->/@*3G63Z+4^TX@Q:H8.4.L]%^
MOX'IU%%%?3GY6%<_XT\):9XZ\%ZEX3UF2XCL-114E:W8+(`'##!(('*CM704
M4`<G'X`T%?&TGBR3SY[R31AH3PRL&A>V#[^5QRQ)P3G&.U5O`OP_\/?"WPQ?
MZ1X:2\:QEN9;\Q2N)75F4`HF`.,*``<GWKM:0@&@#RKX7Z=X!U'X/WGA'PA?
MW\VC-]JM;A;LA;J$S%BX88&T_.<''YX-/\-_!BS\*SZ7_9GQ"\;-9:8R&'3I
M=4#6Q1>D;($&4[8]*Y?XC>&=>^'OBN3XJ>`8]T4G.LZ:`2DJYR9-H['OCE3\
MPZFO2_`GQ!\/^/M&%]H]QLN(P/M%G(1YMNWN.Z^C#@_I7-3K>][.>DOS]#T<
M1A$J:Q%#6F_OB^S_`$?4X;Q#;?#CP5=>)]$\666KC2_'%PUS?7MQ#YEF)&4*
M45U&8R,`C(R#@@\5T'A[P%X0NK'P1=Z9XDO-;B\(>:=-N#=QS%EDC\O;(57Y
M@JX`Z$8'6O0;RSM-0LY+.^MHKJVE&UX9D#HX]"#P:\DUC]G[PQ-=M?\`A35=
M1\)WC'/^@3$Q9_W<@C\&%5-U8N\5=?<11CA:D5&HW"7?=/Y;K\367X)^#K:?
MQO+ILNH:8?&D8BU%;655"#+;C$"IV[M[9SG[QQBK&L?!?P#J_A"Q\-QZ2FEI
MI[0/;7VGQQQ7430XV-YFTDGCDGKFN"G^%GQMM/W>E_%E[B$<+Y\LJ-C\F_G6
M3=?!GXS:R#'K/Q$22(\$-?7#`_\``0H%8O$5%_R[?X'9'+\,]7B8V])?E8]`
M\::U\-_"_CRP\=:[K\DFO:;82:?#8VLBR-(CL&8F,#(;(ZD@5PNF?%#X;:A\
M1=6UZQ\.>)M4UCQ%9QZ;/8""*6.2),@`(&SR"<Y./I5C0_V7]-AD6;Q%XFN+
MOG+Q64(A#?5V+']!7M'ACP3X7\'6AM_#NCP66X8>4#=+)_O.<L?SI1>)F[NT
M5][-*JRNA#E@Y5)=_A7^9YSIW[/WA%K>QAN]4\3R>'8)%NXO"U[J.^Q@DSN"
ME`"2%/\`#N(SGK7H#^!=#E\>7OC&=99KR^TH:--;R$&!K<.7QMQU))!YQCM7
M3@8X%+7<>">4V7P%\$:?X$B\$6\VI?V$FL#67MGG5A,XQB)R5YB^5?EZ\=:Z
M&]^&'A*X\6:!XHL;%='U+0I9'@?38XX!,LB[724!?G4C\1SS7:T4`>2VOP+T
MO3=0O;K1O'OC328KV^DU":TLM46*`RR-N8[0G0]/H*]9R!UIDLT4$#SSR)%%
M&I9W=@JJ!U))Z"OF?XK_`!Y%Y'/X<\"7+"%LQW&JKP6'=8?;_;_+UK"M7A1C
MS3._!8&MC:GLZ2]7T7J/^/'Q8CN%N/`GANY#IG9J=U&W!_Z8*1_X\?P]:^<^
ME`&.E=M\.?ASJ_Q#U[[+;![;2[=@;R^*_+&/[B^KGL.W4U\S4G4Q-3;5GZCA
MZ&'RK"V;LEJWW?\`6R.E^!_PW?QCXG77-3MR="TN0,VX<7,PY6,>H'!;\!WK
M[*48K,T+1-,\.:':Z+H]JMM96B;(T7]23W).23W)K3%?1X;#JA#EZ]3\TS3,
M)X^NZCTBM$O+_-A11174>4%%%%`!1110`UE5E*L`01@@C.:^>?B!\&]7T/6C
MXW^%4LME>QL9)=/MVVGGJ8NQ![QG@]O2OHBDP#VK&K1C55I'9A,95PD^:GL]
MT]FNS1\]>"?VC+1F&D_$"Q;3;R,^6]]#&?+R./WD?WHSZXR/85[QIFK:9K-B
ME]I-_;WUK(,K+;R!U/XBN,\=_"3PGX\1KB^MS8ZKC"ZA:@+)[!QT<?7GT(KY
MWUCX5?%+X;7KZGX<N+N[MEY^V:0[!\?]-(NOZ,*XW4KT/C7,NZW/:CALOQ^M
M&7LI_P`K^'Y/^O0^R*,`5\?:+^T7X^TH_9]6AL=96,[6\^(P2CZE<#/U6N^T
M[]J'1'51JOA6_MF[FVF28?KM-7#'T);NWJ85N'\=3>D>9>37_#GT)17C4/[2
M'PYD4&1=6@/H]GG_`-!8U*W[1GPV`XGU-_863?U-;?6J/\R.)Y5C?^?,ON9[
M!17@]]^T[X2A4C3]!U:\/;S!'$/_`$(G]*XO6/VF_$MR'30_#UCIP/`DN)&G
M<?@-H_G6<L=0C]JYTTLBQ]3_`)=V]6D?518*I9B`!R2:\S\8_&[P3X2$EO'>
MC6M23C[)8L'P?1Y/NK^I]J^4/$?Q"\:^*PR:YXBNYX&/-O&WE0_]\)@'\<UR
MPVKA1@9X`%<%7,V]*:^\^APG"R3YL5._DO\`/_@'>>._BKXK\>R-!?W`LM*S
ME=.MB1&?3>>KGZ\>@K@R0HR2`!7?^%/A!X[\7,DEKI#Z?8MS]LOP8DQZJN-S
M?@,>]?1?@;X$>$O";Q7^I*=>U5/F$UR@\J(^J1\C/N<GZ5RPPU?$RYI?>SUJ
M^:8#+*?LJ5FU]F/ZO_/4\0^&WP1USQG)#JFM+-H^@$AM[+MFN1Z1J>@/]X_@
M#7UQH>A:3X<T:WT?1;*.RLK<82*,?F2>I)[D\FM(`#M2U[F'PT*"]W?N?!9C
MFE?'SO4=HK9+9?\`!$I110*ZCR@Q1BEHH`3%&*6B@!,48I:*`$Q1BEHH`3%&
M*6B@#FO$'@+PAXJ!.O\`A^RO9"/]<T>V4?1UPWZUY?J_[,OA"[8OH^L:EI;'
MG:S+.@_!@#^M>ZT5A/#TJGQ1.[#YABL/I2J-+M?3[MCY7O?V7_$,;-_9WBK3
MIU[>?`\9_0M68?V:/'@8@:GHI'KYTG_Q%?7=%<SR^@^GXGJQXCQZ5G)/Y(^1
M!^S1X\)P=3T4#_KM)_\`$5H6?[+_`(FD8?;_`!1ID"]_)ADD/Z[:^JZ*2RZ@
MNGXA+B/'M64DODCP72?V8O#%LP?6=?U'4<=4B"VZG\LG]:],\/?#;P1X7*R:
M+X<LX)U_Y>'3S9?^^WR1^%==1753P]*GK&)YE?,<7B-*M1M=KV7W+00`CO1B
3EHK<\\3%&*6B@!,4H&***`/_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
